WealthPlan Investment Management LLC Grows Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

WealthPlan Investment Management LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 32.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 941 shares of the healthcare conglomerate’s stock after buying an additional 230 shares during the quarter. WealthPlan Investment Management LLC’s holdings in UnitedHealth Group were worth $550,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at $27,000. Macroview Investment Management LLC increased its stake in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Delos Wealth Advisors LLC increased its position in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the second quarter worth $31,000. Finally, Global Wealth Strategies & Associates boosted its position in UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on UNH. Cantor Fitzgerald increased their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Truist Financial restated a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Barclays decreased their price objective on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. KeyCorp began coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target on the stock. Finally, Morgan Stanley dropped their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Three investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Performance

Shares of UNH opened at $615.01 on Wednesday. The firm has a 50-day moving average price of $582.63 and a 200 day moving average price of $546.78. The firm has a market capitalization of $565.98 billion, a PE ratio of 40.07, a P/E/G ratio of 1.84 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to analyst estimates of $99.14 billion. During the same period last year, the company posted $6.56 EPS. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.37%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.